Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Antidepressant treatment in Alzheimer's disease.

Brodaty H.

Lancet. 2011 Jul 30;378(9789):375-6. doi: 10.1016/S0140-6736(11)61031-3. Epub 2011 Jul 19. No abstract available.

PMID:
21764117
2.

Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.

Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Knapp M, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A.

Lancet. 2011 Jul 30;378(9789):403-11. doi: 10.1016/S0140-6736(11)60830-1. Epub 2011 Jul 19. Review.

PMID:
21764118
3.

Stay the course--is it justified?

Sepehry AA, Lee PE, Hsiung GY, Jacova C.

Lancet. 2012 Jan 21;379(9812):220. doi: 10.1016/S0140-6736(12)60102-0. No abstract available.

PMID:
22265630
4.

A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease.

Magai C, Kennedy G, Cohen CI, Gomberg D.

Am J Geriatr Psychiatry. 2000 Winter;8(1):66-74.

PMID:
10648297
5.

Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.

Behnke K, Søgaard J, Martin S, Bäuml J, Ravindran AV, Agren H, Vester-Blokland ED.

J Clin Psychopharmacol. 2003 Aug;23(4):358-64. Erratum in: J Clin Psychopharmacol. 2003 Dec;23(6):682.

PMID:
12920411
6.

Pseudohallucinations associated with moclobemide: a case report.

Degner D, Kropp S, Porzig J, Grohmann R, Rüther E.

Pharmacopsychiatry. 2005 Jul;38(4):179-81.

PMID:
16025422
7.

A double-blind, multicentre study of paroxetine and mianserin in depression.

Mertens C, Pintens H.

Acta Psychiatr Scand Suppl. 1989;350:140. No abstract available.

PMID:
2530770
8.

A double-blind out-patient trial of indalpine vs mianserin.

Naylor GJ, Martin B.

Br J Psychiatry. 1985 Sep;147:306-9.

PMID:
3904886
9.

A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia.

Karlsson I, Godderis J, Augusto De Mendonça Lima C, Nygaard H, Simányi M, Taal M, Eglin M.

Int J Geriatr Psychiatry. 2000 Apr;15(4):295-305.

PMID:
10767728
10.

Prophylaxis of depression in older people.

Kumar S.

Br J Psychiatry. 2003 Oct;183:365; author reply 365. No abstract available.

11.
12.

The use of mirtazapine in difficult-to-treat patient populations.

Hirschfeld RM.

Hum Psychopharmacol. 2002 Jun;17 Suppl 1:S33-6. Review.

PMID:
12404668
13.

SSRIs in the treatment of depression in Parkinson's disease.

Leentjens AF, Vreeling FW, Luijckx GJ, Verhey FR.

Int J Geriatr Psychiatry. 2003 Jun;18(6):552-4. No abstract available.

PMID:
12789682
14.

Delirium associated with duloxetine in a depressed patient with Alzheimer's dementia.

Suzuki Y, Saito M, Someya T.

Psychiatry Clin Neurosci. 2012 Mar;66(2):166. doi: 10.1111/j.1440-1819.2011.02316.x. No abstract available.

15.
16.

Paroxetine in the treatment of depression. A double-blind multicenter study versus mianserin.

Mertens C, Pintens H.

Acta Psychiatr Scand. 1988 Jun;77(6):683-8.

PMID:
2970203
17.

The expert consensus guideline series. Treatment of dementia and its behavioral disturbances.

Expert Consensus Panel for Dementia.

Postgrad Med. 2005 Jan;Spec No:1-111. No abstract available.

PMID:
17203560
18.

Evidence of early onset of antidepressant effect in randomized controlled trials.

Stahl SM, Nierenberg AA, Gorman JM.

J Clin Psychiatry. 2001;62 Suppl 4:17-23; discussion 37-40. Review.

19.

Reemergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline.

Ferguson JM, Shrivastava RK, Stahl SM, Hartford JT, Borian F, Ieni J, McQuade RD, Jody D.

J Clin Psychiatry. 2001 Jan;62(1):24-9.

PMID:
11235924
20.

Supplemental Content

Support Center